Liver X receptors as integrators of metabolic and inflammatory signaling

被引:805
作者
Zelcer, N [1 ]
Tontonoz, P [1 ]
机构
[1] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90055 USA
关键词
D O I
10.1172/JCI27883
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The liver X receptors (LXRs) are nuclear receptors that play central roles in the transcriptional control of lipid metabolism. LXRs function as nuclear cholesterol sensors that are activated in response to elevated intracellular cholesterol levels in multiple cell types. Once activated, LXRs induce the expression of an array of genes involved in cholesterol absorption, efflux, transport, and excretion. In addition to their function in lipid metabolism, LXRs have also been found to modulate immune and inflammatory responses in macrophages. Synthetic LXR agonists promote cholesterol efflux and inhibit inflammation in vivo and inhibit the development of atherosclerosis in animal models. The ability of LXRs to integrate metabolic and inflammatory signaling makes them particularly attractive targets for intervention in human metabolic disease.
引用
收藏
页码:607 / 614
页数:8
相关论文
共 95 条
[1]   Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages [J].
Aiello, RJ ;
Brees, D ;
Bourassa, PA ;
Royer, L ;
Lindsey, S ;
Coskran, T ;
Haghpassand, M ;
Francone, OL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) :630-637
[2]   Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice [J].
Alberti, S ;
Schuster, G ;
Parini, P ;
Feltkamp, D ;
Diczfalusy, U ;
Rudling, M ;
Angelin, B ;
Björkhem, I ;
Pettersson, S ;
Gustafsson, JÅ .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05) :565-573
[3]   A NOVEL ORPHAN RECEPTOR-SPECIFIC FOR A SUBSET OF THYROID HORMONE-RESPONSIVE ELEMENTS AND ITS INTERACTION WITH THE RETINOID/THYROID HORMONE-RECEPTOR SUBFAMILY [J].
APFEL, R ;
BENBROOK, D ;
LERNHARDT, E ;
ORTIZ, MA ;
SALBERT, G ;
PFAHL, M .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) :7025-7035
[4]   A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development [J].
Arai, S ;
Shelton, JM ;
Chen, MY ;
Bradley, MN ;
Castrillo, A ;
Bookout, AL ;
Mak, PA ;
Edwards, PA ;
Mangelsdorf, DJ ;
Tontonoz, P ;
Miyazaki, T .
CELL METABOLISM, 2005, 1 (03) :201-213
[5]  
Berge KE, 2002, J LIPID RES, V43, P486
[6]   Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-α agonist in mice:: Effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo [J].
Beyer, TP ;
Schmidt, RJ ;
Foxworthy, P ;
Zhang, YY ;
Dai, JN ;
Bensch, WR ;
Kauffman, RF ;
Gao, H ;
Ryan, TP ;
Jiang, XC ;
Karathanasis, SK ;
Eacho, PI ;
Cao, GQ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (03) :861-868
[7]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[8]   Mammalian ABC transporters in health and disease [J].
Borst, P ;
Elferink, RO .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :537-592
[9]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[10]   Chlamydia pneumoniae and atherosclerosis:: Links to the disease process [J].
Byrne, GI ;
Kalayoglu, MV .
AMERICAN HEART JOURNAL, 1999, 138 (05) :S488-S490